Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2015

01.12.2015 | Breast Oncology

Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center

verfasst von: Mehra Golshan, MD, FACS, Katya Losk, MPH, Melissa A. Mallory, MD, Kristen Camuso, MPH, Susan Troyan, MD, Nancy U. Lin, MD, Sarah Kadish, MS, Craig A. Bunnell, MD, MPH, MBA

Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

In the multidisciplinary care model, breast imagers frequently provide second-opinion reviews of imaging studies performed at outside institutions. However, the need for additional imaging and timeliness of obtaining these studies has yet to be established. We sought to evaluate the frequency of additional imaging orders by breast surgeons and to evaluate the impact of this supplementary imaging on timeliness of surgery.

Methods

We identified 2489 consecutive women with breast cancer who underwent first definitive surgery (FDS) at our comprehensive cancer center between 2011 and 2013. The number of breast-specific imaging studies performed for each patient between initial consultation and FDS was obtained. χ 2 tests were used to quantify the proportion of patients undergoing additional imaging by surgeon. Interval time between initial consultation and additional imaging and/or biopsy was calculated. The delay of additional imaging on time to FDS was assessed by t test.

Results

Of 2489 patients, 615 (24.7 %) had at least one additional breast-specific imaging study performed between initial consultation and FDS, with 222 patients undergoing additional biopsies (8.9 %). The proportion of patients receiving imaging tests by breast surgeon ranged from 15 to 39 % (p < 0.0001). Patients receiving additional imaging had statistically longer wait times to FDS for BCT (21.4–28.5 days, p < 0.0001).

Conclusions

Substantial variability exists in the utilization of additional breast-specific imaging and in the timeliness of obtaining these tests among breast surgeons. Further research is warranted to assess the sources and impact of this variation on patient care, cost, and outcomes.
Literatur
1.
Zurück zum Zitat Geller BM, Nelson HD, Carney PA, et al. Second opinion in breast pathology: policy, practice, and perception. J Clin Pathol. 2014;0:1–6. Geller BM, Nelson HD, Carney PA, et al. Second opinion in breast pathology: policy, practice, and perception. J Clin Pathol. 2014;0:1–6.
2.
Zurück zum Zitat Staradub VL, Messenger KA, Hao N, Morrow, M. Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol. 2002;9:982–7.PubMedCrossRef Staradub VL, Messenger KA, Hao N, Morrow, M. Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol. 2002;9:982–7.PubMedCrossRef
3.
Zurück zum Zitat Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management. Cancer. 2001;91(7):1231–7.PubMedCrossRef Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management. Cancer. 2001;91(7):1231–7.PubMedCrossRef
4.
Zurück zum Zitat Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;207(10):2346–51.CrossRef Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;207(10):2346–51.CrossRef
6.
Zurück zum Zitat Mallory MA, Losk K, Lin NU, et al. The influence of radiology image consultation in the surgical management of breast cancer patients. Ann Surg Oncol. 2015. doi:10.1245/s10434-015-4663-4. Mallory MA, Losk K, Lin NU, et al. The influence of radiology image consultation in the surgical management of breast cancer patients. Ann Surg Oncol. 2015. doi:10.​1245/​s10434-015-4663-4.
7.
Zurück zum Zitat Hulvat M, Sandalow N, Rademaker A, Helenowski, I, Hansen, NW. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery. 2010;148(4):746–51.PubMedCrossRef Hulvat M, Sandalow N, Rademaker A, Helenowski, I, Hansen, NW. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery. 2010;148(4):746–51.PubMedCrossRef
8.
Zurück zum Zitat Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanijian K, Lum SS. Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg. 2010;76(10):1119–22.PubMed Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanijian K, Lum SS. Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg. 2010;76(10):1119–22.PubMed
9.
Zurück zum Zitat Nessim C, Winocour J, Holloway D, Saskin R, Holloway CM. Wait times for breast cancer surgery: effect of magnetic resonance imaging and preoperative investigations on the diagnostic pathway. J Oncol Pract. 2015;11(2):e131–8.PubMedCrossRef Nessim C, Winocour J, Holloway D, Saskin R, Holloway CM. Wait times for breast cancer surgery: effect of magnetic resonance imaging and preoperative investigations on the diagnostic pathway. J Oncol Pract. 2015;11(2):e131–8.PubMedCrossRef
10.
Zurück zum Zitat Angarita FA, Acuna SA, Fonseca A, Crytal P, Escallon J. Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol. 2010;17:273–9.PubMedCrossRef Angarita FA, Acuna SA, Fonseca A, Crytal P, Escallon J. Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol. 2010;17:273–9.PubMedCrossRef
11.
Zurück zum Zitat Bleicher RJ, Ruth K, Sigurdson ER, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30(36):4485–92.PubMedPubMedCentralCrossRef Bleicher RJ, Ruth K, Sigurdson ER, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30(36):4485–92.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Golshan M, Losk K, Kadish S, et al. Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center. Breast Cancer Res Treat. 2014;148(1):125–33.PubMedCrossRef Golshan M, Losk K, Kadish S, et al. Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center. Breast Cancer Res Treat. 2014;148(1):125–33.PubMedCrossRef
13.
Zurück zum Zitat Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79(5-6):858–64.PubMedPubMedCentralCrossRef Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79(5-6):858–64.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Sue GR, Lannin DR, Killelea B, Tsangaris T, Chagpar AB. Does time to definitive treatment matter in patients with ductal carcinoma in situ? Am Surg. 2013;79(6):561–5.PubMed Sue GR, Lannin DR, Killelea B, Tsangaris T, Chagpar AB. Does time to definitive treatment matter in patients with ductal carcinoma in situ? Am Surg. 2013;79(6):561–5.PubMed
15.
Zurück zum Zitat Landercasper J, Linebarger JH, Ellis RL, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210(4):449–55.PubMedCrossRef Landercasper J, Linebarger JH, Ellis RL, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210(4):449–55.PubMedCrossRef
16.
Zurück zum Zitat Hislop TG, Harris SR, Jachskon J, et al. Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat. 2002;76:245–54.PubMedCrossRef Hislop TG, Harris SR, Jachskon J, et al. Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat. 2002;76:245–54.PubMedCrossRef
17.
Zurück zum Zitat Del Turco MR, Pont A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46:2344–56.PubMedCrossRef Del Turco MR, Pont A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46:2344–56.PubMedCrossRef
18.
Zurück zum Zitat McCahill LE, Privette A, James T, et al. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg. 2009;144:455–62.PubMedCrossRef McCahill LE, Privette A, James T, et al. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg. 2009;144:455–62.PubMedCrossRef
19.
Zurück zum Zitat Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait time for cancer surgery in the United States: trends and predictors of delay. Ann Surg. 2011;253(4):779–85.PubMedCrossRef Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait time for cancer surgery in the United States: trends and predictors of delay. Ann Surg. 2011;253(4):779–85.PubMedCrossRef
20.
Zurück zum Zitat Liederbach E, Sisco M, Wang C, et al. Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899–907.PubMedCrossRef Liederbach E, Sisco M, Wang C, et al. Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899–907.PubMedCrossRef
21.
Zurück zum Zitat Cordeiro E, Dixon M, Coburn N, Holloway CM. A patient centered approach to wait times in the surgical management of breast cancer in the province of Ontario. Ann Surg Oncol. 2015;22(8):2509–16.PubMedCrossRef Cordeiro E, Dixon M, Coburn N, Holloway CM. A patient centered approach to wait times in the surgical management of breast cancer in the province of Ontario. Ann Surg Oncol. 2015;22(8):2509–16.PubMedCrossRef
Metadaten
Titel
Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer Center
verfasst von
Mehra Golshan, MD, FACS
Katya Losk, MPH
Melissa A. Mallory, MD
Kristen Camuso, MPH
Susan Troyan, MD
Nancy U. Lin, MD
Sarah Kadish, MS
Craig A. Bunnell, MD, MPH, MBA
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 3/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4834-3

Weitere Artikel der Sonderheft 3/2015

Annals of Surgical Oncology 3/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.